834 related articles for article (PubMed ID: 32791101)
1. The Immunomodulatory Metabolite Itaconate Modifies NLRP3 and Inhibits Inflammasome Activation.
Hooftman A; Angiari S; Hester S; Corcoran SE; Runtsch MC; Ling C; Ruzek MC; Slivka PF; McGettrick AF; Banahan K; Hughes MM; Irvine AD; Fischer R; O'Neill LAJ
Cell Metab; 2020 Sep; 32(3):468-478.e7. PubMed ID: 32791101
[TBL] [Abstract][Full Text] [Related]
2. Itaconate confers tolerance to late NLRP3 inflammasome activation.
Bambouskova M; Potuckova L; Paulenda T; Kerndl M; Mogilenko DA; Lizotte K; Swain A; Hayes S; Sheldon RD; Kim H; Kapadnis U; Ellis AE; Isaguirre C; Burdess S; Laha A; Amarasinghe GK; Chubukov V; Roddy TP; Diamond MS; Jones RG; Simons DM; Artyomov MN
Cell Rep; 2021 Mar; 34(10):108756. PubMed ID: 33691097
[TBL] [Abstract][Full Text] [Related]
3. Itaconate and fumarate derivatives inhibit priming and activation of the canonical NLRP3 inflammasome in macrophages.
Hoyle C; Green JP; Allan SM; Brough D; Lemarchand E
Immunology; 2022 Apr; 165(4):460-480. PubMed ID: 35137954
[TBL] [Abstract][Full Text] [Related]
4. OLT1177, a β-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation.
Marchetti C; Swartzwelter B; Gamboni F; Neff CP; Richter K; Azam T; Carta S; Tengesdal I; Nemkov T; D'Alessandro A; Henry C; Jones GS; Goodrich SA; St Laurent JP; Jones TM; Scribner CL; Barrow RB; Altman RD; Skouras DB; Gattorno M; Grau V; Janciauskiene S; Rubartelli A; Joosten LAB; Dinarello CA
Proc Natl Acad Sci U S A; 2018 Feb; 115(7):E1530-E1539. PubMed ID: 29378952
[TBL] [Abstract][Full Text] [Related]
5. Dimethyl itaconate inhibits LPS‑induced microglia inflammation and inflammasome‑mediated pyroptosis via inducing autophagy and regulating the Nrf‑2/HO‑1 signaling pathway.
Yang S; Zhang X; Zhang H; Lin X; Chen X; Zhang Y; Lin X; Huang L; Zhuge Q
Mol Med Rep; 2021 Sep; 24(3):. PubMed ID: 34296312
[TBL] [Abstract][Full Text] [Related]
6. NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux.
He Y; Zeng MY; Yang D; Motro B; Núñez G
Nature; 2016 Feb; 530(7590):354-7. PubMed ID: 26814970
[TBL] [Abstract][Full Text] [Related]
7. IRG1/itaconate alleviates acute liver injury in septic mice by suppressing NLRP3 expression and its mediated macrophage pyroptosis via regulation of the Nrf2 pathway.
Zhou P; Yang L; Li R; Yin Y; Xie G; Liu X; Shi L; Tao K; Zhang P
Int Immunopharmacol; 2024 Jun; 135():112277. PubMed ID: 38788445
[TBL] [Abstract][Full Text] [Related]
8. Glucose regulates hypoxia-induced NLRP3 inflammasome activation in macrophages.
Watanabe S; Usui-Kawanishi F; Karasawa T; Kimura H; Kamata R; Komada T; Inoue Y; Mise N; Kasahara T; Takahashi M
J Cell Physiol; 2020 Oct; 235(10):7554-7566. PubMed ID: 32115713
[TBL] [Abstract][Full Text] [Related]
9. PLK4 deubiquitination by Spata2-CYLD suppresses NEK7-mediated NLRP3 inflammasome activation at the centrosome.
Yang XD; Li W; Zhang S; Wu D; Jiang X; Tan R; Niu X; Wang Q; Wu X; Liu Z; Chen LF; Qin J; Su B
EMBO J; 2020 Jan; 39(2):e102201. PubMed ID: 31762063
[TBL] [Abstract][Full Text] [Related]
10. HSP70 is a negative regulator of NLRP3 inflammasome activation.
Martine P; Chevriaux A; Derangère V; Apetoh L; Garrido C; Ghiringhelli F; Rébé C
Cell Death Dis; 2019 Mar; 10(4):256. PubMed ID: 30874540
[TBL] [Abstract][Full Text] [Related]
11. Glutathione Transferase Omega-1 Regulates NLRP3 Inflammasome Activation through NEK7 Deglutathionylation.
Hughes MM; Hooftman A; Angiari S; Tummala P; Zaslona Z; Runtsch MC; McGettrick AF; Sutton CE; Diskin C; Rooke M; Takahashi S; Sundararaj S; Casarotto MG; Dahlstrom JE; Palsson-McDermott EM; Corr SC; Mills KHG; Preston RJS; Neamati N; Xie Y; Baell JB; Board PG; O'Neill LAJ
Cell Rep; 2019 Oct; 29(1):151-161.e5. PubMed ID: 31577945
[TBL] [Abstract][Full Text] [Related]
12. Selective inhibition of NLRP3 inflammasome by designed peptide originating from ASC.
Sušjan P; Lainšček D; Strmšek Ž; Hodnik V; Anderluh G; Hafner-Bratkovič I
FASEB J; 2020 Aug; 34(8):11068-11086. PubMed ID: 32648626
[TBL] [Abstract][Full Text] [Related]
13. Sulforaphane attenuates activation of NLRP3 and NLRC4 inflammasomes but not AIM2 inflammasome.
Lee J; Ahn H; Hong EJ; An BS; Jeung EB; Lee GS
Cell Immunol; 2016; 306-307():53-60. PubMed ID: 27423466
[TBL] [Abstract][Full Text] [Related]
14. Saturated Fatty Acids Undergo Intracellular Crystallization and Activate the NLRP3 Inflammasome in Macrophages.
Karasawa T; Kawashima A; Usui-Kawanishi F; Watanabe S; Kimura H; Kamata R; Shirasuna K; Koyama Y; Sato-Tomita A; Matsuzaka T; Tomoda H; Park SY; Shibayama N; Shimano H; Kasahara T; Takahashi M
Arterioscler Thromb Vasc Biol; 2018 Apr; 38(4):744-756. PubMed ID: 29437575
[TBL] [Abstract][Full Text] [Related]
15. Pristimerin protects against inflammation and metabolic disorder in mice through inhibition of NLRP3 inflammasome activation.
Zhao Q; Bi Y; Guo J; Liu YX; Zhong J; Pan LR; Tan Y; Yu XJ
Acta Pharmacol Sin; 2021 Jun; 42(6):975-986. PubMed ID: 32989235
[TBL] [Abstract][Full Text] [Related]
16. Gallic Acid Alleviates Gouty Arthritis by Inhibiting NLRP3 Inflammasome Activation and Pyroptosis Through Enhancing Nrf2 Signaling.
Lin Y; Luo T; Weng A; Huang X; Yao Y; Fu Z; Li Y; Liu A; Li X; Chen D; Pan H
Front Immunol; 2020; 11():580593. PubMed ID: 33365024
[TBL] [Abstract][Full Text] [Related]
17. Anti-inflammatory effect of artemisinin on uric acid-induced NLRP3 inflammasome activation through blocking interaction between NLRP3 and NEK7.
Kim SK; Choe JY; Park KY
Biochem Biophys Res Commun; 2019 Sep; 517(2):338-345. PubMed ID: 31358323
[TBL] [Abstract][Full Text] [Related]
18. The zebrafish NLRP3 inflammasome has functional roles in ASC-dependent interleukin-1β maturation and gasdermin E-mediated pyroptosis.
Li JY; Wang YY; Shao T; Fan DD; Lin AF; Xiang LX; Shao JZ
J Biol Chem; 2020 Jan; 295(4):1120-1141. PubMed ID: 31852739
[TBL] [Abstract][Full Text] [Related]
19. RACK1 Mediates NLRP3 Inflammasome Activation by Promoting NLRP3 Active Conformation and Inflammasome Assembly.
Duan Y; Zhang L; Angosto-Bazarra D; Pelegrín P; Núñez G; He Y
Cell Rep; 2020 Nov; 33(7):108405. PubMed ID: 33207200
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in the NEK7-licensed NLRP3 inflammasome activation: Mechanisms, role in diseases and related inhibitors.
Zhao N; Li CC; Di B; Xu LL
J Autoimmun; 2020 Sep; 113():102515. PubMed ID: 32703754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]